0001140361-16-058277.txt : 20160317
0001140361-16-058277.hdr.sgml : 20160317
20160317172449
ACCESSION NUMBER: 0001140361-16-058277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160315
FILED AS OF DATE: 20160317
DATE AS OF CHANGE: 20160317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howard Elizabeth
CENTRAL INDEX KEY: 0001669530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 161513348
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
4
1
doc1.xml
FORM 4
X0306
4
2016-03-15
0
0001447028
Arbutus Biopharma Corp
ABUS
0001669530
Howard Elizabeth
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Exec. VP & General Counsel
Employee Stock Option (Right to Buy)
3.94
2016-03-15
4
A
0
120000
0.0
A
2026-03-07
Common Shares
120000
120000
D
The options vest as follows: 1/3 on March 7, 2017; 1/3 on March 7, 2018; and 1/3 on March 7, 2019.
/s/ Elizabeth Howard
2016-03-16